 Ryan Bachtell
Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 22 | 2023 | 149 | 5.470 |
Why?
| | Drug-Seeking Behavior | 7 | 2023 | 22 | 3.650 |
Why?
| | Cocaine-Related Disorders | 14 | 2023 | 108 | 3.530 |
Why?
| | Central Nervous System Stimulants | 8 | 2023 | 154 | 2.520 |
Why?
| | Methamphetamine | 5 | 2023 | 55 | 2.450 |
Why?
| | Nucleus Accumbens | 13 | 2019 | 126 | 2.410 |
Why?
| | Receptor, Adenosine A2A | 6 | 2018 | 20 | 2.310 |
Why?
| | Conditioning, Operant | 10 | 2017 | 104 | 2.080 |
Why?
| | Self Administration | 25 | 2023 | 120 | 1.930 |
Why?
| | Dopamine Uptake Inhibitors | 9 | 2016 | 55 | 1.820 |
Why?
| | Receptors, Dopamine D2 | 6 | 2018 | 90 | 1.610 |
Why?
| | Toll-Like Receptor 4 | 6 | 2023 | 263 | 1.560 |
Why?
| | Dopamine Agonists | 9 | 2018 | 39 | 1.560 |
Why?
| | Receptor, Adenosine A1 | 4 | 2014 | 11 | 1.440 |
Why?
| | Rats | 31 | 2024 | 5482 | 1.380 |
Why?
| | Extinction, Psychological | 9 | 2023 | 89 | 1.320 |
Why?
| | Rats, Sprague-Dawley | 24 | 2023 | 2396 | 1.220 |
Why?
| | Ethanol | 12 | 2016 | 589 | 1.200 |
Why?
| | Behavior, Animal | 13 | 2016 | 506 | 1.140 |
Why?
| | Caffeine | 3 | 2018 | 62 | 1.090 |
Why?
| | Receptors, AMPA | 5 | 2013 | 141 | 1.020 |
Why?
| | Adenosine A2 Receptor Agonists | 5 | 2018 | 21 | 1.010 |
Why?
| | Central Nervous System Depressants | 5 | 2016 | 82 | 0.920 |
Why?
| | Ventral Tegmental Area | 5 | 2019 | 52 | 0.910 |
Why?
| | Behavior, Addictive | 3 | 2017 | 80 | 0.890 |
Why?
| | Dose-Response Relationship, Drug | 14 | 2023 | 2008 | 0.880 |
Why?
| | Analgesia | 1 | 2024 | 100 | 0.810 |
Why?
| | Alcohol Drinking | 6 | 2016 | 763 | 0.770 |
Why?
| | Locomotion | 3 | 2018 | 100 | 0.770 |
Why?
| | Adenosine A2 Receptor Antagonists | 2 | 2018 | 9 | 0.730 |
Why?
| | Proto-Oncogene Proteins c-fos | 10 | 2008 | 175 | 0.690 |
Why?
| | Animals | 44 | 2024 | 35307 | 0.680 |
Why?
| | Brain | 11 | 2023 | 2669 | 0.680 |
Why?
| | Reward | 5 | 2016 | 240 | 0.660 |
Why?
| | Corticotropin-Releasing Hormone | 6 | 2016 | 61 | 0.660 |
Why?
| | Neuroglia | 3 | 2017 | 163 | 0.650 |
Why?
| | Opioid-Related Disorders | 2 | 2024 | 483 | 0.650 |
Why?
| | Receptors, Dopamine D1 | 4 | 2013 | 29 | 0.620 |
Why?
| | Receptors, Purinergic P1 | 2 | 2023 | 26 | 0.600 |
Why?
| | Substance-Related Disorders | 3 | 2017 | 1019 | 0.560 |
Why?
| | Analgesics, Opioid | 4 | 2024 | 909 | 0.540 |
Why?
| | Quinpirole | 5 | 2014 | 10 | 0.530 |
Why?
| | Adenosine | 6 | 2014 | 227 | 0.530 |
Why?
| | Motor Activity | 9 | 2018 | 675 | 0.510 |
Why?
| | Microglia | 2 | 2019 | 232 | 0.510 |
Why?
| | Phenethylamines | 5 | 2014 | 23 | 0.500 |
Why?
| | Encephalitis | 1 | 2017 | 132 | 0.490 |
Why?
| | Astrocytes | 1 | 2017 | 196 | 0.490 |
Why?
| | Xenobiotics | 1 | 2015 | 29 | 0.460 |
Why?
| | Pituitary-Adrenal System | 1 | 2016 | 148 | 0.460 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2016 | 181 | 0.450 |
Why?
| | Dopamine | 6 | 2019 | 287 | 0.430 |
Why?
| | Male | 38 | 2023 | 63501 | 0.410 |
Why?
| | Genes, fos | 2 | 2003 | 33 | 0.400 |
Why?
| | Substance Withdrawal Syndrome | 3 | 2011 | 176 | 0.400 |
Why?
| | Immunity, Innate | 1 | 2017 | 803 | 0.370 |
Why?
| | Sucrose | 6 | 2016 | 99 | 0.340 |
Why?
| | Gene Expression Regulation | 5 | 2016 | 2537 | 0.320 |
Why?
| | Anxiety | 1 | 2016 | 962 | 0.310 |
Why?
| | Naltrexone | 2 | 2023 | 87 | 0.300 |
Why?
| | Septum of Brain | 2 | 2003 | 4 | 0.260 |
Why?
| | Cues | 2 | 2023 | 325 | 0.260 |
Why?
| | Neural Pathways | 3 | 2008 | 302 | 0.260 |
Why?
| | Dopamine Antagonists | 1 | 2005 | 23 | 0.250 |
Why?
| | Aging | 1 | 2016 | 1774 | 0.250 |
Why?
| | Pyrimidines | 3 | 2014 | 459 | 0.240 |
Why?
| | Tegmentum Mesencephali | 1 | 2004 | 5 | 0.230 |
Why?
| | Purinergic P1 Receptor Agonists | 2 | 2014 | 9 | 0.220 |
Why?
| | Oxycodone | 1 | 2024 | 42 | 0.220 |
Why?
| | Hypothermia, Induced | 1 | 2004 | 76 | 0.210 |
Why?
| | Adenosine A1 Receptor Agonists | 2 | 2014 | 2 | 0.210 |
Why?
| | Microinjections | 2 | 2013 | 86 | 0.200 |
Why?
| | Drinking Behavior | 2 | 2016 | 10 | 0.190 |
Why?
| | Alcoholism | 3 | 2003 | 765 | 0.190 |
Why?
| | Hypothermia | 1 | 2002 | 34 | 0.190 |
Why?
| | Narcotic Antagonists | 4 | 2019 | 164 | 0.190 |
Why?
| | Urocortins | 5 | 2004 | 22 | 0.180 |
Why?
| | Excitatory Amino Acid Agonists | 2 | 2013 | 40 | 0.180 |
Why?
| | Excitatory Amino Acid Antagonists | 2 | 2013 | 100 | 0.180 |
Why?
| | Signal Transduction | 6 | 2019 | 4926 | 0.180 |
Why?
| | Immediate-Early Proteins | 1 | 2001 | 51 | 0.180 |
Why?
| | Mice, Inbred C57BL | 9 | 2004 | 5439 | 0.170 |
Why?
| | Drug Interactions | 3 | 2013 | 393 | 0.170 |
Why?
| | Pyrazoles | 2 | 2014 | 404 | 0.170 |
Why?
| | Nerve Net | 1 | 2003 | 260 | 0.170 |
Why?
| | Benzazepines | 2 | 2013 | 39 | 0.160 |
Why?
| | Lipopolysaccharides | 1 | 2023 | 877 | 0.160 |
Why?
| | Lymphocyte Antigen 96 | 1 | 2019 | 24 | 0.160 |
Why?
| | Food Preferences | 2 | 2014 | 112 | 0.160 |
Why?
| | Stress, Psychological | 2 | 2018 | 1065 | 0.160 |
Why?
| | Dorsal Raphe Nucleus | 1 | 2018 | 29 | 0.150 |
Why?
| | Serotonergic Neurons | 1 | 2018 | 28 | 0.150 |
Why?
| | Cell Count | 3 | 2004 | 311 | 0.150 |
Why?
| | Amygdala | 2 | 2016 | 198 | 0.150 |
Why?
| | Immunohistochemistry | 6 | 2008 | 1691 | 0.150 |
Why?
| | Transcription Factors | 3 | 2001 | 1647 | 0.150 |
Why?
| | Reinforcement Schedule | 2 | 2016 | 30 | 0.150 |
Why?
| | Nicotine | 1 | 2001 | 302 | 0.150 |
Why?
| | Interleukin-1beta | 2 | 2017 | 372 | 0.140 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 2 | 2015 | 47 | 0.140 |
Why?
| | Immune System | 1 | 2018 | 175 | 0.140 |
Why?
| | Mice | 13 | 2015 | 16915 | 0.140 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2008 | 110 | 0.140 |
Why?
| | Gene Transfer Techniques | 3 | 2013 | 161 | 0.130 |
Why?
| | Neurons | 5 | 2015 | 1494 | 0.130 |
Why?
| | TRPC Cation Channels | 1 | 2016 | 14 | 0.130 |
Why?
| | Paraventricular Hypothalamic Nucleus | 1 | 2016 | 27 | 0.130 |
Why?
| | Gastrointestinal Microbiome | 1 | 2023 | 640 | 0.130 |
Why?
| | Neuronal Plasticity | 2 | 2008 | 279 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 729 | 0.120 |
Why?
| | Phosphorylation | 4 | 2013 | 1710 | 0.120 |
Why?
| | Dopaminergic Neurons | 1 | 2016 | 57 | 0.120 |
Why?
| | Brain Chemistry | 2 | 2008 | 118 | 0.120 |
Why?
| | Analysis of Variance | 4 | 2012 | 1288 | 0.120 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2016 | 133 | 0.120 |
Why?
| | Receptors, Adenosine A2 | 1 | 2014 | 5 | 0.120 |
Why?
| | Corticosterone | 1 | 2016 | 220 | 0.120 |
Why?
| | RNA, Messenger | 3 | 2017 | 2703 | 0.110 |
Why?
| | 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2013 | 5 | 0.110 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2013 | 15 | 0.100 |
Why?
| | DNA-Binding Proteins | 1 | 2001 | 1446 | 0.100 |
Why?
| | Gene Expression | 2 | 2018 | 1466 | 0.100 |
Why?
| | Central Nervous System | 1 | 2015 | 253 | 0.100 |
Why?
| | Hippocampus | 3 | 2003 | 871 | 0.100 |
Why?
| | Adenosine Deaminase Inhibitors | 1 | 2012 | 2 | 0.100 |
Why?
| | Adenosine Kinase | 1 | 2012 | 2 | 0.100 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2011 | 169 | 0.100 |
Why?
| | Stimulation, Chemical | 1 | 2012 | 63 | 0.100 |
Why?
| | Adenosine Deaminase | 1 | 2012 | 29 | 0.100 |
Why?
| | Mice, Inbred DBA | 2 | 2003 | 190 | 0.100 |
Why?
| | Purinergic P2X Receptor Antagonists | 1 | 2011 | 7 | 0.100 |
Why?
| | Xanthines | 1 | 2011 | 19 | 0.100 |
Why?
| | Receptor, trkB | 2 | 2008 | 30 | 0.090 |
Why?
| | Sweetening Agents | 1 | 2011 | 39 | 0.090 |
Why?
| | Morpholines | 1 | 2012 | 122 | 0.090 |
Why?
| | Disease Models, Animal | 3 | 2011 | 4057 | 0.090 |
Why?
| | Age Factors | 2 | 2018 | 3140 | 0.090 |
Why?
| | Neostriatum | 1 | 2011 | 34 | 0.090 |
Why?
| | Tissue Distribution | 2 | 2002 | 315 | 0.090 |
Why?
| | Recurrence | 1 | 2014 | 1005 | 0.090 |
Why?
| | Naloxone | 3 | 2019 | 112 | 0.090 |
Why?
| | Association Learning | 1 | 2011 | 67 | 0.090 |
Why?
| | Genetic Vectors | 2 | 2008 | 312 | 0.080 |
Why?
| | Tyrosine 3-Monooxygenase | 2 | 2016 | 71 | 0.080 |
Why?
| | Social Environment | 1 | 2011 | 293 | 0.080 |
Why?
| | MAP Kinase Signaling System | 1 | 2011 | 313 | 0.080 |
Why?
| | Presynaptic Terminals | 1 | 2008 | 83 | 0.070 |
Why?
| | Drug Tolerance | 1 | 2007 | 90 | 0.070 |
Why?
| | Impulsive Behavior | 1 | 2008 | 127 | 0.070 |
Why?
| | Anesthetics, Local | 1 | 2007 | 75 | 0.070 |
Why?
| | Glutamic Acid | 1 | 2008 | 235 | 0.070 |
Why?
| | Synaptic Transmission | 1 | 2008 | 272 | 0.070 |
Why?
| | Frontal Lobe | 1 | 2007 | 153 | 0.060 |
Why?
| | Cyclic AMP | 1 | 2007 | 237 | 0.060 |
Why?
| | Humans | 7 | 2023 | 129248 | 0.060 |
Why?
| | Salicylamides | 1 | 2005 | 3 | 0.060 |
Why?
| | Morphine | 2 | 2008 | 137 | 0.060 |
Why?
| | Tetrahydronaphthalenes | 1 | 2005 | 30 | 0.060 |
Why?
| | Prefrontal Cortex | 1 | 2008 | 303 | 0.060 |
Why?
| | Pupil | 1 | 2004 | 13 | 0.060 |
Why?
| | Quinine | 1 | 2004 | 16 | 0.060 |
Why?
| | Body Temperature | 1 | 2004 | 212 | 0.050 |
Why?
| | Cognition Disorders | 1 | 2007 | 505 | 0.050 |
Why?
| | Brain Diseases | 1 | 2004 | 136 | 0.050 |
Why?
| | Crosses, Genetic | 1 | 2003 | 142 | 0.050 |
Why?
| | Aminoacetonitrile | 1 | 2002 | 1 | 0.050 |
Why?
| | Chlordiazepoxide | 1 | 2002 | 1 | 0.050 |
Why?
| | Yohimbine | 1 | 2002 | 9 | 0.050 |
Why?
| | Mesencephalon | 1 | 2002 | 66 | 0.050 |
Why?
| | Female | 4 | 2023 | 68543 | 0.050 |
Why?
| | Time Factors | 3 | 2012 | 6543 | 0.050 |
Why?
| | Haloperidol | 1 | 2002 | 32 | 0.050 |
Why?
| | Mice, Inbred Strains | 1 | 2003 | 406 | 0.050 |
Why?
| | Pregnanolone | 1 | 2002 | 33 | 0.050 |
Why?
| | Down-Regulation | 2 | 2018 | 636 | 0.050 |
Why?
| | Body Temperature Regulation | 1 | 2003 | 96 | 0.050 |
Why?
| | Protease Inhibitors | 1 | 2002 | 106 | 0.050 |
Why?
| | Cold Temperature | 1 | 2003 | 154 | 0.050 |
Why?
| | Chromosome Mapping | 1 | 2003 | 504 | 0.050 |
Why?
| | Norepinephrine | 1 | 2002 | 210 | 0.050 |
Why?
| | Early Growth Response Protein 1 | 1 | 2001 | 26 | 0.040 |
Why?
| | Pentobarbital | 1 | 2000 | 16 | 0.040 |
Why?
| | Species Specificity | 1 | 2002 | 574 | 0.040 |
Why?
| | Exploratory Behavior | 1 | 2001 | 88 | 0.040 |
Why?
| | Hot Temperature | 1 | 2003 | 369 | 0.040 |
Why?
| | Temperature | 1 | 2003 | 634 | 0.040 |
Why?
| | Drug Combinations | 1 | 2001 | 330 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2002 | 768 | 0.040 |
Why?
| | Child | 1 | 2018 | 20773 | 0.040 |
Why?
| | Organic Cation Transport Proteins | 1 | 2018 | 30 | 0.040 |
Why?
| | Reaction Time | 2 | 2012 | 410 | 0.040 |
Why?
| | Receptor, Serotonin, 5-HT1A | 1 | 2018 | 38 | 0.040 |
Why?
| | Tryptophan Hydroxylase | 1 | 2018 | 53 | 0.040 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2018 | 74 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2003 | 742 | 0.040 |
Why?
| | Rats, Long-Evans | 2 | 2008 | 136 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2019 | 217 | 0.030 |
Why?
| | Cerebral Cortex | 1 | 2001 | 436 | 0.030 |
Why?
| | Sex Factors | 1 | 2003 | 1965 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2002 | 736 | 0.030 |
Why?
| | Rats, Transgenic | 1 | 2016 | 18 | 0.030 |
Why?
| | Maze Learning | 1 | 2016 | 104 | 0.030 |
Why?
| | Rats, Inbred F344 | 1 | 2016 | 259 | 0.030 |
Why?
| | NF-kappa B | 1 | 2019 | 665 | 0.030 |
Why?
| | Membrane Potentials | 1 | 2016 | 293 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 2015 | 272 | 0.030 |
Why?
| | Phenotype | 1 | 2003 | 3074 | 0.030 |
Why?
| | Microdialysis | 1 | 2012 | 51 | 0.030 |
Why?
| | Drug Administration Routes | 1 | 2012 | 38 | 0.020 |
Why?
| | Pain Threshold | 1 | 2012 | 79 | 0.020 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2012 | 96 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 184 | 0.020 |
Why?
| | Hyperalgesia | 1 | 2012 | 123 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2012 | 1247 | 0.020 |
Why?
| | Narcotics | 1 | 2008 | 45 | 0.020 |
Why?
| | Integrases | 1 | 2008 | 119 | 0.020 |
Why?
| | Adenoviridae | 1 | 2008 | 192 | 0.020 |
Why?
| | Synapsins | 1 | 2007 | 13 | 0.020 |
Why?
| | Models, Molecular | 1 | 2012 | 1486 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 4076 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2012 | 2117 | 0.020 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2007 | 76 | 0.020 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2007 | 181 | 0.020 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 141 | 0.020 |
Why?
| | Protein Binding | 1 | 2012 | 2120 | 0.020 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 132 | 0.020 |
Why?
| | Hallucinogens | 1 | 2008 | 102 | 0.020 |
Why?
| | Dronabinol | 1 | 2008 | 203 | 0.020 |
Why?
| | Protein Kinase C | 1 | 2007 | 260 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2007 | 756 | 0.020 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2007 | 211 | 0.010 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2007 | 185 | 0.010 |
Why?
| | Mutation | 1 | 2015 | 3710 | 0.010 |
Why?
| | Neuropsychological Tests | 1 | 2007 | 1014 | 0.010 |
Why?
| | Neurotransmitter Agents | 1 | 2003 | 81 | 0.010 |
Why?
| | Hypothalamus | 1 | 2002 | 149 | 0.010 |
Why?
| | Choice Behavior | 1 | 2002 | 164 | 0.010 |
Why?
| | Genes, Immediate-Early | 1 | 2001 | 20 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2007 | 1688 | 0.010 |
Why?
| | Cognition | 1 | 2008 | 1122 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2007 | 2871 | 0.010 |
Why?
| | Anesthetics | 1 | 2000 | 66 | 0.010 |
Why?
| | Brain Mapping | 1 | 2003 | 574 | 0.010 |
Why?
| | Circadian Rhythm | 1 | 2002 | 413 | 0.010 |
Why?
| | Stress, Physiological | 1 | 2000 | 414 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2000 | 742 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2000 | 833 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2000 | 1117 | 0.010 |
Why?
|
|
Bachtell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|